NCT03880682 is a clinical trial in Kidney Transplant; Complications, sponsored by Istanbul University.

Who is sponsoring NCT03880682?

NCT03880682 is sponsored by Istanbul University.

What condition does NCT03880682 study?

NCT03880682 studies Kidney Transplant; Complications, Hepatitis C, Chronic.

Is NCT03880682 still recruiting?

NCT03880682 is currently completed. Last updated 12 November 2019.

Last reviewed 2019-11-12 · How we verify

NCT03880682

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Direct Acting Antivirals for HCV Infection in Kidney Transplant Recipients

Completed Last updated 12 November 2019

What this trial tests

trial in Kidney Transplant; Complications in 30 participants. Completed in 31 October 2019.

Timeline

1 November 2018

Primary endpoint
15 June 2019

31 October 2019

Quick facts

Lead sponsor	Istanbul University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 November 2018
Primary completion	15 June 2019
Estimated completion	31 October 2019
Sites	1 location across Turkey (Türkiye)

Conditions studied

Kidney Transplant; Complications — all drugs for Kidney Transplant; Complications →
Hepatitis C, Chronic — all drugs for Hepatitis C, Chronic →

Sponsor

Istanbul University

Who can join

18 and older, any sex, with Kidney Transplant; Complications or Hepatitis C, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic hepatitis C virus (HCV) infection, an important cause of morbidity and mortality worldwide, is a significant problem in kidney transplant recipients (KTRs) given its high prevalence in patients undergoing hemodialysis. Interferon based regimens were cornerstone of treatment of HCV infection in the past; however, due to their low efficacy and high rates of adverse effects, they have been abandoned in the new era of direct acting antivirals (DAAs). Several studies demonstrated the efficacy and safety of DAAs, yet data regarding clinical practice of these agents in KTRs is still needed. Therefore, we conducted a study using our registry data to evaluate the efficacy and safety of DAAs in KTRs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Kidney Transplant; Complications

Currently open trials in the same condition.

NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
NCT06958796 — Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV) · Phase 4 · recruiting
NCT06798909 — Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients · Phase 3 · recruiting
NCT07033858 — Evaluaion the Short Term Effects of Advograf Plus Rapamiune After Kidney Transplantation · NA · recruiting
NCT05782543 — Renal Ex Vivo Warm Advanced Resuscitation Through Machine Perfusion · NA · recruiting

Other Istanbul University trials

Trials by the same sponsor.

NCT07472946 — Whole-Body Vibration Exercise in Patients With Parkinson's Disease · NA · not yet recruiting
NCT07433894 — Scoliosis and Functional Outcomes in Children With Juvenile Idiopathic Arthritis · not yet recruiting
NCT07420049 — Turkish Adaptation of the CTS-6 Evaluation Tool: A Validation and Reliability Study · not yet recruiting
NCT07415967 — The Effect of a Dual-Task Technique-Based Exercise Program on Clinical Outcomes in Rotator Cuff Related Shoulder Pain · NA · recruiting
NCT07473024 — pEEG-Guided Anesthesia and Behavioral Outcomes in Children · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03880682 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul University
Last refreshed: 12 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03880682.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing